Ardsley Advisory Partners’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-60,000
| Closed | -$4.79M | – | 130 |
|
|
2022
Q2 | $4.79M | Sell |
60,000
-25,000
| -29% | -$1.99M | 0.79% | 28 |
|
|
2022
Q1 | $8.94M | Sell |
85,000
-55,000
| -39% | -$5.79M | 1.49% | 18 |
|
|
2021
Q4 | $15.1M | Sell |
140,000
-136,000
| -49% | -$14.7M | 2.88% | 5 |
|
|
2021
Q3 | $30.2M | Sell |
276,000
-9,000
| -3% | -$986K | 4.61% | 3 |
|
|
2021
Q2 | $26.7M | Buy |
285,000
+35,000
| +14% | +$3.28M | 3.14% | 3 |
|
|
2021
Q1 | $23M | Buy |
250,000
+50,000
| +25% | +$4.6M | 2.8% | 8 |
|
|
2020
Q4 | $14.6M | Buy |
200,000
+65,000
| +48% | +$4.75M | 2.4% | 11 |
|
|
2020
Q3 | $10.5M | Buy |
+135,000
| New | +$10.5M | 2.02% | 12 |
|
|
2017
Q3 | – | Sell |
-40,000
| Closed | -$475K | – | 164 |
|
|
2017
Q2 | $475K | Buy |
40,000
+16,500
| +70% | +$196K | 0.07% | 77 |
|
|
2017
Q1 | $347K | Buy |
+23,500
| New | +$347K | 0.05% | 93 |
|
|
2015
Q1 | – | Sell |
-15,000
| Closed | -$193K | – | 238 |
|
|
2014
Q4 | $193K | Buy |
+15,000
| New | +$193K | 0.03% | 140 |
|